Company intelligence / Profile preview

James Brown Veterinary Products

Reading, United Kingdom

Ownership: Private
Development stage: Other

Overview

James Brown Veterinary Products was a specialized pharmaceutical company focused on the development and distribution of veterinary medicines and healthcare products for livestock and companion animals. Based in the United Kingdom, the company provided a range of anti-infectives, vaccines, and nutritional supplements tailored for the agricultural sector. It was particularly known for its portfolio of treatments for cattle and swine. The company was eventually acquired by Bimeda, a global leader in animal health, which integrated the James Brown product line into its broader international distribution network.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: Small moleculeVaccine
Industry: Veterinary

Beyond the preview

Go deeper on James Brown Veterinary Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on James Brown Veterinary Products.

Explore the full profile